Abstract:Ureteral stricture caused by holmium: YAG laser lithotripsy is one of the most challenging issues for urologists. Currently, evidence for rapamycin application in reducing ureterostenosis is not sufficient. This study aimed to assess the inhibition of ureteral stricture of rapamycin-eluting stents in vitro and in vivo . A bilayer drug-eluting ureteral stent consisted of drug blending with poly (lactic-co-glycolic acid) (PU/drug stent), which was over-layered by polycaprolactone (PCL) by ultrasonic atomizing spraying. Stent morphology was observed by scanning electron microscope. A kidney-ureter-bladder model was established to simulate the stents-releasing condition, and high-performance liquid chromatography was used to measure the drug release rate. The inhibitory proliferation was detected by CCK-8. The bladder of rats was injured through electro tome, and stents were implanted for 7, 14, and 28 days. The effects of drug-eluting stents was investigated by hematoxylin-eosin staining, immunofluorescence staining, real-time quantitative polymerase chain reaction and western blot. The bilayer stents could block the burst loss of the drug and maintained a sustained delivery period because of the 5.3 μm thickness of the PCL layer. The relative growth rates of cells plotted inhibitory effect on the proliferation of human urethral scar fibroblast cells. For in vivo results of 28 days, the bilayer stent maintained structural integrity and induced less deposition of crystals, thinner and less lamina propria connective tissues were formed, and α-SMA and TGF-β1 were downregulated. Bilayer rapamycin-eluting stent is significantly effective in alleviating fibrosis in in vitro and in vivo models. Statement of significance The occurrence of ureteral stricture resulting from holmium: YAG laser lithotripsy presents a significant challenge for urologists. Traditional double J stents have not been proven to offer a shorter indwelling time or improved inhibition of tissue blocking. While drug-eluting stents containing rapamycin, paclitaxel, and other substances have been extensively used in treating artery stenosis, there is insufficient evidence supporting their application in reducing ureterostenosis. Consequently, a biodegradable polymer ureteric scaffold incorporating rapamycin was fabricated in this study, employing ultrasonic atomization spraying technology to optimize the bilayers composed of 75/25 poly (lactic-co-glycolic acid) (PLGA) and polycaprolactone (PCL). The efficacy of the scaffold was subsequently confirmed through in vitro and in vivo experiments.

In vitro and in vivo study of antibacterial and anti‐encrustation coating on ureteric stents

In vitro and in vivo studies on bacteria and encrustation resistance of heparin/poly-L-lysine-Cu nanoparticles coating mediated by PDA for ureteral stent application

New insights into the prevention of ureteral stents encrustation

Smart Lubricant Coating with Urease‐Responsive Antibacterial Functions for Ureteral Stents to Inhibit Infectious Encrustation

Polyvinylpyrrolidone hydrogel coating for ureteral stent: Safety and performance evaluation

Improvement of Hydrophilicity and Formation of Heparin/chitosan Coating Inhibits Stone Formation in Ureteral Stents

A new hydrophilic biodegradable ureteral stent restrain encrustation both in vitro and in vivo

MP44-09 A PROSPECTIVE, RANDOMIZED, SINGLE-BLIND STUDY OF URETERAL STENT BIOMATERIAL ENCRUSTATION AFTER URETEROSCOPIC LITHOTROPISY

Surface Modification of Zn-Cu Alloy with Heparin Nanoparticles for Urinary Implant Applications

Inner surface modification of polyurethane ureteral stents using plasma-enhanced chemical vapor deposition to improve the resistance to encrustation in a pig model

Bio-inspired Antibacterial Coatings on Urinary Stents for Encrustation Prevention.

Interactive Effects of Copper-Doped Urological Implants with Tissue in the Urinary Tract for the Inhibition of Cell Adhesion and Encrustation in the Animal Model Rat

In vitro antibacterial test of the surface antibacterial coating of a new nano-silver/polyurethane biliary stent

Comparison of Ureteral Stent Biomaterials: Encrustation Profile in Lithogenic Artificial Urine Models

The interplay between bacterial biofilms, encrustation, and wall shear stress in ureteral stents: a review across scales

Problems and solutions of stent biofilm and encrustations: A review of literature

In-vitro activity of triclosan-eluting ureteral stents against common bacterial uropathogens

Recent development and future application of biodegradable ureteral stents

In vitro and in vivo assessment of a bilayered degradable rapamycin-eluting stent for ureteral stricture caused by holmium: YAG laser lithotripsy

MP05-09 URETERAL STENT BIOFILMS EXHIBIT COMPLEX INTERACTION NETWORKS AND VARIABLE FORMATION BY SURFACE MATERIAL AND MICROBIAL STRAIN

Silicone-hydrocoated ureteral stents encrustation and biofilm formation after 3-week dwell time: results of a prospective randomized multicenter clinical study